Ridhima Kapoor, MD
Cardiovascular Disease (Cardiology) · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 5
- 2 carriers
- Office
- 1
Offices
1 location · Stanford Health Care · 3,152 clinicians in this group
Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
5 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Kapoor’s office at (650) 723-4000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
5 of 5 plans
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A162742 · Current
Licensed to practise in California · since 2019 · expires 2027-05-31 · Rosalind Franklin University, the Chicago Medical School.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$5,099
Medicare paid this office $5,099 for 15 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
Procedures Medicare counted
| Pacemaker insertion or repair | 1-10 | None |
Who their Medicare patients are
15 Original Medicare patients in 2024. Average age 77 · Under 65 0% · Health risk score 2.81. Sicker patients than 9 in 10 peers; the typical cardiology clinician is at 1.71.
Conditions among them: High blood pressure 75% · Coronary heart disease 75% · Atrial fibrillation 75% · Chronic kidney disease 73%.
The office billed $33,368, Medicare allowed $6,364 and paid $5,099; for 23 services of 13 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 15 | 23 | 77 | 2.81 | $33,368 | $5,099 |
| 2023 | 49 | 75 | 75 | 2.31 | $65,701 | $10,378 |
| 2022 | 304 | 450 | 72 | 2.63 | $281,999 | $18,517 |
| 2021 | 254 | 372 | 72 | 2.22 | $113,434 | $10,362 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 2 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 12 | $789 | $66 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 16 | $666 | $42 |
2022: 2 services
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 201 | $1,547 | $6 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 12 | $174 | $15 |
2021: 3 services
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 179 | $1,647 | $6 |
| Long return visit (40+ min) | 12 | $1,459 | $112 |
| Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring, transmission and review and report by health care professional | 20 | $388 | $19 |
Medicaid work
$2,115 in 2022
Medicaid paid $2,115 for 371 billed services this clinician did in 2022, up to 120 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 371 | $2,115 |
| 2022 | 371 | 1 | 120 | $2,115 |
| 2021 | 396 | 1 | 157 | $2,203 |
See the largest Medicaid services in earlier years
2021
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 396 | $2,203 |
Drugs they prescribed that Part D paid
$5,981
Pharmacies billed $5,981 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 24) in 2024. Too few prescriptions to compare fairly with other clinicians.
0 generic and 20 brand-name prescriptions · $5,981 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 20 | $5,939 | $297 |
Year by year
| 2024 | 24 | None | 0% (0) | 83% | $5,981 |
| 2023 | 38 | None | 0% (0) | 82% | $10,396 |
| 2022 | 220 | 59 | None | 27% | $49,667 |
| 2021 | 35 | 25 | None | None | $8,171 |
| 2020 | 25 | 18 | 0% (0) | None | $1,951 |
| 2017 | 12 | None | 0% (0) | None | $200 |
| 2016 | 49 | None | None | 24% | $2,230 |
| 2015 | 20 | None | 0% (0) | None | $642 |
| 2014 | 29 | 14 | 0% (0) | None | $1,535 |
| 2013 | 28 | 13 | 0% (0) | None | $754 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 1 drug
| Eliquis | 28 | $8,479 | $303 |
2022: 6 drugs
| Eliquis | 58 | $43,293 | $746 |
| Metoprolol | 74 | $1,777 | $24 |
| Flecainide Acetate | 13 | $641 | $49 |
| Amiodarone | 23 | $549 | $24 |
| Sotalol | 13 | $340 | $26 |
| Mupirocin | 11 | $94 | $9 |
2016: 1 drug
| Generlac | 13 | $217 | $17 |
Money from drug and device companies
$9,207 in 2025
| 2025 | 5 | 45 | $4,613 | $9,207 |
| 2024 | 2 | 38 | None | $6,104 |
| 2023 | 3 | 16 | None | $3,299 |
| 2022 | 3 | 9 | None | $879 |
| 2021 | 5 | 39 | None | $5,247 |
| 2020 | 3 | 29 | $5,000 | $33,549 |
| 2019 | 3 | 31 | None | $18,732 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Abbott Laboratories | Gallant | $4,832 | 22 payments
|
| Medtronic | Affera Mapping System | $2,079 | 19 payments
|
| Impulse Dynamics (USA) | None | $2,000 | 1 payment
|
| AtriCure | Epi-Sense Guided Coagulation System With Visitrax | $148 | 1 payment
|
| Boston Scientific | General - Ep | $147 | 2 payments
|
See all 45 published payments
| Impulse Dynamics (USA) | Consulting · 2025-07-25 | None | $2,000 |
| Boston Scientific | Meals · 2025-07-22 | Farapulse | $24 |
| Medtronic | Meals · 2025-06-19 | None | $133 |
| Abbott Laboratories | Meals · 2025-06-16 | Ensite Precision | $96 |
| Abbott Laboratories | Meals · 2025-05-30 | Ensite Precision | $120 |
| Abbott Laboratories | Paid to speak or teach · 2025-05-22 | Gallant | $1,900 |
| Abbott Laboratories | Paid to speak or teach · 2025-05-22 | Gallant | $713 |
| Medtronic | Meals · 2025-05-19 | None | $71 |
| Boston Scientific | Meals · 2025-04-26 | General - Ep | $124 |
| AtriCure | Meals · 2025-04-24 | Epi-Sense Guided Coagulation System With Visitrax | $148 |
| Medtronic | Meals · 2025-04-11 | None | $22 |
| Abbott Laboratories | Meals · 2025-03-25 | Ensite | $22 |
| Medtronic | Travel · 2025-03-10 | None | $89 |
| Medtronic | Travel · 2025-03-09 | None | $50 |
| Medtronic | Meals · 2025-03-09 | Affera Mapping System | $39 |
| Medtronic | Meals · 2025-03-09 | None | $59 |
| Medtronic | Meals · 2025-03-09 | None | $52 |
| Medtronic | Meals · 2025-03-09 | None | $28 |
| Medtronic | Travel · 2025-03-08 | None | $179 |
| Medtronic | Travel · 2025-03-08 | None | $31 |
| Medtronic | Meals · 2025-03-08 | None | $60 |
| Medtronic | Meals · 2025-03-08 | None | $78 |
| Medtronic | Meals · 2025-03-08 | None | $71 |
| Medtronic | Meals · 2025-03-07 | Affera Mapping System | $31 |
| Medtronic | Travel · 2025-03-07 | None | $179 |
| Medtronic | Travel · 2025-03-07 | None | $31 |
| Medtronic | Meals · 2025-03-07 | None | $205 |
| Medtronic | Travel · 2025-03-05 | None | $668 |
| Abbott Laboratories | Travel · 2025-03-05 | Ensite Precision | $213 |
| Abbott Laboratories | Travel · 2025-03-05 | Ensite Precision | $9 |
| Abbott Laboratories | Meals · 2025-02-22 | Ensite Precision | $94 |
| Abbott Laboratories | Meals · 2025-02-22 | Ensite Precision | $41 |
| Abbott Laboratories | Meals · 2025-02-22 | Ensite Precision | $83 |
| Abbott Laboratories | Meals · 2025-02-22 | Ensite Precision | $36 |
| Abbott Laboratories | Meals · 2025-02-21 | Ensite Precision | $88 |
| Abbott Laboratories | Meals · 2025-02-21 | Ensite Precision | $43 |
| Abbott Laboratories | Meals · 2025-02-21 | Ensite Precision | $120 |
| Abbott Laboratories | Meals · 2025-02-21 | Ensite Precision | $48 |
| Abbott Laboratories | Meals · 2025-02-21 | Ensite Precision | $68 |
| Abbott Laboratories | Meals · 2025-02-21 | Ensite Precision | $167 |
| Abbott Laboratories | Travel · 2025-02-21 | Ensite Precision | $374 |
| Abbott Laboratories | Travel · 2025-02-20 | Ensite Precision | $175 |
| Abbott Laboratories | Travel · 2025-02-20 | Ensite Precision | $374 |
| Abbott Laboratories | Meals · 2025-02-17 | Ensite | $19 |
| Abbott Laboratories | Meals · 2025-02-03 | Ensite Precision | $28 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $6,104
| Medtronic | Micra | $4,692 | 25 payments
|
| Abbott Laboratories | Aveir | $1,412 | 13 payments
|
2023: $3,299
| Abbott Laboratories | Aveir | $3,107 | 14 payments
|
| Boston Scientific | Lux-Dx Insertable Cardiac Monitor | $105 | 1 payment
|
| Medtronic | Cobalt Dr Mri Surescan | $87 | 1 payment
|
2022: $879
| Medtronic | Micra | $480 | 4 payments
|
| Abbott Laboratories | Ensite Precision | $382 | 4 payments
|
| Janssen Pharmaceuticals | Xarelto | $18 | 1 payment
|
2021: $5,247
| Medtronic | Micra | $2,427 | 12 payments
|
| Abbott Laboratories | Ensite Precision Cardiac Mapping System | $2,417 | 21 payments
|
| Biotronik | Edora | $233 | 4 payments
|
| Atricure | Epi-Sense Guided Coagulation System With Visitrax | $120 | 1 payment
|
| Biosense Webster | Carto 3 | $50 | 1 payment
|
2020: $33,549
| Medtronic Vascular | Micra | $22,533 | 5 payments
|
| Abbott Laboratories | Ensite Cardiac Mapping System | $6,801 | 22 payments
|
| Boston Scientific | General - Brady | $4,215 | 2 payments
|
2019: $18,732
| Medtronic Vascular | Arctic Front | $15,497 | 20 payments
|
| Boston Scientific | General Therapies | $3,017 | 9 payments
|
| Abbott Laboratories | Ensite Cardiac Mapping System | $217 | 2 payments
|
Professional record
- NPI
- 1750624193
- Licence
- CA A162742, WI 63509California A162742: Current · expires 2027-05-31
- Group
- Stanford Health Care
- Gender
- Female
More record details
- Sole proprietor
- No
- Medicaid ID
- WI 1750624193
- Taxonomy
- Federal specialty code 207RC0001X (207RC0001X); Internal medicine (207R00000X); Cardiology (207RC0000X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2013-04-04
- NPI last updated
- 2024-04-22
- NPI record certified
- 2024-04-22
This is when the NPI record was last certified, not a medical board exam.